Earnings Call for Q2FY22 of IDBI Bank
Conference Call with IDBI Bank Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.21-10-2021
21-10-2021
IDBI Bank Ltd - 500116 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Notice in respect of loss of share certificates (Lot No. 355)21-10-2021
IDBI Bank Ltd - 500116 - Disclosure For Statement Of Deviation(S) Or Variation(S) Under Regulation 32(1) Of SEBI (LODR) Regulations, 2015
The Bank has not raised capital during the period July to September 2021 and there has been no deviation in utilisation of funds raised earlier by the Bank and the earlier funds have been fully utilised by the Bank. Hence, nil form is being submitted as per the prescribed format. We are unable to file under XBRL mode as the form does not allow NIL entry. Kindly acknowledge the receipt and take the above on record in terms of Regulation 32(1) of the SEBI (LODR) Regulations, 2015.21-10-2021
Q2FY22 Quarterly Result Announced for IDBI Bank Ltd.
Highlights: IDBI Bank reports Net Profit at Rs 567 crore, YoY growth of 75% CRAR stood at 16.59%, YoY growth of 292 bps Net profit of Rs 567 crore for Q2 FY 2022 against net profit of Rs 324 crore for Q2 FY 2021, YoY growth 75%. Operating Profit for Q2 FY 2022 is Rs 1,209 crore, YoY growth of 15%. NII at Rs 1,854 crore for Q2 FY 2022, YoY growth of 9%. NIM at 3.02 % for Q2 FY 2022, YoY growth of 32 bps. CRAR at 16.59 % for Q2 FY 2022, YoY growth of 292 bps. Return on Assets (ROA) stands at 0.78% for Q2 FY 2022, YoY growth by 35 bps. Return on Equity (ROE) stands at 12.91% for Q2 FY 2022, YoY growth by 266 bps. CASA ratio at 54.64%, YoY growth of 631 bps. Net NPA at 1.62% as against 2.67% as on September 30, 2020. CRAR at 16.59% as against 13.67% as on September 30, 2020. PCR stood at 97.27% as against 95.96 % as on September 30, 2020. Result PDF21-10-2021
IDBI Bank Ltd - 500116 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Further to Bank''s disclosure dated October 14, 2021 on the captioned subject, please find attached a copy of the Press Release proposed to be issued by the Bank on the subject. You are requested to kindly take the above intimation on record in terms of Regulation 30 of the SEBI (LODR) Regulations, 2015.21-10-2021
IDBI Bank Ltd - 500116 - Announcement under Regulation 30 (LODR)-Investor Presentation
In continuation of Bank''s letter dated October 18, 2021 advising the exchange about a conference call with Shareholders/ Investors/ Analysts for Financial Results for Q2 for FY 2021-22 proposed to be held at 5 p.m. on October 21, 2021, please find attached the copy of the presentation being provided to the Shareholders/ Investors/ Analysts. Kindly take the information on record in terms of SEBI (LODR) Regulations, 2015.21-10-2021
IDBI Bank Ltd - 500116 - Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021 And Limited Review Report Submitted By Statutory Auditors
In terms of Regulations 33 and 52 of the SEBI (LODR) Regulations, 2015, we advise that the Board of Directors of IDBI Bank Ltd., at their meeting held on Thursday, October 21, 2021, have taken on record the Un-audited Financial Results of the Bank for the quarter and half year ended September 30, 2021. We enclose a statement of the results approved at the above meeting. The Board Meeting commenced at 11.00 a.m. and concluded at 12.45 p.m. Further, please fmd enclosed the Limited Review Report for the quarter and half year ended September 30, 2021 received from G. D. Apte & Co. and Varma & Varma, Statutory Auditors of IDBI Bank Ltd. Kindly acknowledge receipt and take the above on record.21-10-2021
Top headlines: Govt plans IDBI sale; chief economist Gopinath to leave IMF
India's drug regulator is examining recommendation by experts for approving Bharat Biotech's Covaxin for children. More in top headlines this morning.20-10-2021
IDBI BANK LTD. - 500116 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In compliance of Regulation 30 read with Para A of Schedule III and Regulation 46(2) of the SEBI (LODR) Regulations, 2015, we advise that a conference call with Analysts for Financial Results for Q2 for FY 2021-22 is proposed to be held on October 21, 2021 at 5:00 p.m. You are requested to kindly take the above intimation on record in terms of the aforesaid provisions of SEBI (LODR) Regulations, 2015.18-10-2021
IDBI BANK LTD. - 500116 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021
IDBI BANK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2021 ,inter alia, to consider and approve the Un-audited Financial Results of the Bank for the quarter and half year ended September 30, 2021 subject to a Limited Review by the Statutory Auditors. Kindly acknowledge receipt and take the above on record.14-10-2021